About tRNA pseudouridine synthase Pus10
tRNA pseudouridine synthase Pus10 (PUS10) is a protein
from Homo sapiens identified by UniProt accession
Q3MIT2, 529 residues long.
MolForge cross-references it against 0 known binders and
54 disease associations.
Target properties
| Protein name | tRNA pseudouridine synthase Pus10 |
| UniProt accession | Q3MIT2 |
| Gene | PUS10 |
| Organism | Homo sapiens |
| Length | 529 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (54)
Diseases linked to this target (Open Targets).
- peroxisome biogenesis disorder 11A (Zellweger) · score 0.51
- Zellweger syndrome · score 0.51
- Crohn's disease · score 0.47
- ulcerative colitis · score 0.47
- inflammatory bowel disease · score 0.46
- celiac disease · score 0.45
- psoriasis · score 0.35
- lymphocyte count · score 0.34
- autoimmune disease · score 0.31
- ankylosing spondylitis · score 0.31
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q3MIT2-F1 | alphafold | PREDICTED | 88.32 | — |
Amino-acid sequence (529 residues)
MFPLTEENKH VAQLLLNTGT CPRCIFRFCG VDFHAPYKLP YKELLNELQK FLETEKDELI LEVMNPPPKK IRLQELEDSI DNLSQNGEGR ISVSHVGSTA SKNSNLNVCN VCLGILQEFC EKDFIKKVCQ KVEASGFEFT SLVFSVSFPP QLSVREHAAW LLVKQEMGKQ SLSLGRDDIV QLKEAYKWIT HPLFSEELGV PIDGKSLFEV SVVFAHPETV EDCHFLAAIC PDCFKPAKNK QSVFTRMAVM KALNKIKEED FLKQFPCPPN SPKAVCAVLE IECAHGAVFV AGRYNKYSRN LPQTPWIIDG ERKLESSVEE LISDHLLAVF KAESFNFSSS GREDVDVRTL GNGRPFAIEL VNPHRVHFTS QEIKELQQKI NNSSNKIQVR DLQLVTREAI GHMKEGEEEK TKTYSALIWT NKAIQKKDIE FLNDIKDLKI DQKTPLRVLH RRPLAVRARV IHFMETQYVD EHHFRLHLKT QAGTYIKEFV HGDFGRTKPN IGSLMNVTAD ILELDVESVD VDWPPALDD
Explore tRNA pseudouridine synthase Pus10 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets